V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 170009164 | 170003362 | null | null | null | null | 2018-10-17 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101744647 |
| 170009503 | 170003367 | null | null | null | null | 2019-02-21 | null | null | null | CARBOPLATIN + ETOPOSIDE | 100726592 |
| 170010318 | 170003379 | null | null | null | null | 2021-03-02 | null | null | null | FULVESTRANT + PALBOCICLIB | 100009704 |
| 170010597 | 170003381 | null | null | null | null | 2017-05-06 | null | null | null | TEMOZOLOMIDE + RT | 100934538 |
| 170010809 | 170003385 | null | null | null | null | 2021-08-26 | null | null | null | CAPECITABINE + OXALIPLATIN | 101486395 |
| 170011893 | 170003400 | null | null | null | null | 2022-05-08 | null | null | null | IPILIMUMAB + NIVOLUMAB | 100626385 |
| 170013946 | 170003417 | null | null | null | null | 2019-12-10 | null | null | null | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | 101821108 |
| 170014545 | 170003430 | null | null | null | null | 2019-09-13 | null | null | null | NIVOLUMAB | 100495877 |
| 170014964 | 170003439 | null | null | null | null | 2020-07-18 | null | null | null | CARBOPLATIN + PEMETREXED | 101720186 |
| 170015748 | 170003456 | null | null | null | null | 2020-08-11 | null | null | null | HYDROXYCARBAMIDE | 101190142 |
| 170000031 | 170003500 | null | null | null | 2020-02-05 | 2020-02-05 | Carboplatin + Pemetrexed | null | null | LETROZOLE + PALBOCICLIB | 100674607 |
| 170000068 | 170003501 | null | null | Palliative (P) | null | 2016-11-15 | PACLITAXEL | 02 | N | BEVACIZUMAB | 100233968 |
| 170000078 | 170003503 | null | null | null | 2020-02-17 | 2021-04-20 | null | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101753635 |
| 170000087 | 170003504 | 1.68 | 89.7 | null | 2018-03-20 | 2018-08-06 | null | 02 | null | HYDROXYCARBAMIDE | 100430136 |
| 170000251 | 170003509 | 1.9 | 66.4 | null | null | 2020-07-24 | null | null | null | LIPOSOMAL DOXORUBICIN | 100797596 |
| 170000383 | 170003512 | null | null | null | null | 2020-05-04 | Atezolizumab | null | null | CYTARABINE | 101080601 |
| 170000401 | 170003513 | null | null | null | null | 2022-01-14 | null | null | null | TRASTUZUMAB | 100098803 |
| 170000497 | 170003516 | 0 | null | null | 2017-01-07 | 2017-01-07 | DARATUMUMAB | null | null | TEMOZOLOMIDE | 100064902 |
| 170000506 | 170003517 | null | 72.6 | 03 | null | 2019-10-28 | null | 02 | N | LENALIDOMIDE | 101829264 |
| 170000532 | 170003518 | null | 69.1 | null | null | 2022-05-18 | Oxaliplatin + Modified de Gramont | 02 | null | TEMOZOLOMIDE | 101100086 |
| 170000630 | 170003522 | null | null | null | 2017-05-04 | 2017-05-12 | null | 01 | null | CISPLATIN | 100012154 |
| 170000644 | 170003523 | null | null | Disease modification (D) | null | 2019-11-11 | null | N | N | CYTARABINE HIGH DOSE | 100894817 |
| 170000715 | 170003525 | 1.64 | null | null | 2020-01-05 | 2020-01-12 | Niraparib | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 101684115 |
| 170000763 | 170003527 | null | null | null | null | 2020-12-22 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | TEMOZOLOMIDE | 101095407 |
| 170000839 | 170003529 | null | null | null | null | 2019-10-18 | Eribulin | null | null | LENALIDOMIDE | 101704546 |
| 170000893 | 170003530 | null | null | Palliative (P) | null | 2018-01-29 | Bevacizumab | 02 | N | FULVESTRANT + PALBOCICLIB | 100576976 |
| 170000984 | 170003532 | 1.69 | 66.4 | Palliative (P) | 2021-05-25 | 2021-09-01 | null | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100506226 |
| 170001222 | 170003535 | null | null | null | null | 2018-09-12 | null | 02 | null | CISPLATIN + VINORELBINE | 100844957 |
| 170001272 | 170003537 | null | null | null | 2021-03-31 | 2021-05-23 | Trial Unspecified | null | null | FLUOROURACIL + OXALIPLATIN | 101364617 |
| 170001308 | 170003541 | 1.62 | 54.7 | null | null | 2018-07-16 | LENALIDOMIDE | 02 | null | MELPHALAN | 101720450 |
| 170001333 | 170003542 | 1.59 | 95.7 | null | null | 2012-09-13 | BUSULFAN | 02 | null | MELPHALAN | 100893226 |
| 170001469 | 170003544 | 1.64 | 34.45 | Palliative (P) | null | 2020-09-04 | CYCLOPHOSPHAMIDE | 02 | N | FEC | 100048003 |
| 170001483 | 170003545 | null | null | null | 2019-12-02 | 2019-12-02 | null | 02 | null | CNS LGG 2004 03 CONS VINC + CARBO | 101372137 |
| 170001532 | 170003547 | 1.64 | null | 03 | null | 2019-03-16 | null | 02 | N | CISPLATIN + GEMCITABINE | 101128149 |
| 170001637 | 170003551 | null | 78 | null | 2021-11-29 | 2021-11-29 | null | N | null | CAPECITABINE | 100442022 |
| 170001639 | 170003552 | 0 | 62 | null | 2006-11-09 | 2016-03-02 | null | null | null | TEMOZOLOMIDE | 100053174 |
| 170001730 | 170003554 | 1.85 | 54.7 | Adjuvant (A) | 2022-03-13 | 2022-03-18 | Bevacizumab | 99 | N | PEMBROLIZUMAB | 101831860 |
| 170001745 | 170003555 | null | 98.5 | null | 2022-04-18 | 2022-05-06 | Epirubicin (weekly) | N | null | IMATINIB | 100051452 |
| 170001787 | 170003556 | null | null | null | null | 2022-04-16 | null | null | null | CISPLATIN + CYCLOPHOSPHAMIDE + DOXORUBICIN | 101110492 |
| 170001817 | 170003558 | null | null | null | 2017-02-23 | 2018-07-23 | Docetaxel 100mg/m2 (21 day) | null | null | CARBOPLATIN | 100607697 |
| 170001882 | 170003560 | null | null | null | null | 2020-04-17 | null | null | null | BEVACIZUMAB | 100500669 |
| 170001919 | 170003561 | null | null | null | null | 2019-08-19 | Cisplatin + Pemetrexed | null | null | LENALIDOMIDE | 100971547 |
| 170001939 | 170003563 | null | null | null | null | 2019-03-23 | Bevacizumab | null | null | LIPOSOMAL DOXORUBICIN | 101024140 |
| 170001992 | 170003567 | null | null | null | 2021-08-06 | 2021-08-06 | Temozolomide 150mg/m2 | null | null | DOXORUBICIN + IFOSFAMIDE | 101572930 |
| 170002118 | 170003568 | null | 56.4 | Palliative (P) | null | 2019-11-17 | null | 02 | Y | TRANSPLANT MELPHALAN AUTOLOGOUS | 100846835 |
| 170002129 | 170003569 | 1.55 | null | null | 2020-06-18 | 2021-02-15 | Melphalan IV High dose | null | null | PEMBROLIZUMAB | 100141732 |
| 170002132 | 170003570 | null | 73.2 | null | null | 2019-12-05 | null | null | null | TRASTUZUMAB | 101450956 |
| 170002137 | 170003571 | 1.5 | 98.5 | null | 2021-10-10 | 2021-10-12 | PEMBROLIZUMAB | null | null | BEVACIZUMAB | 101207031 |
| 170002260 | 170003572 | null | null | Palliative (P) | 2018-08-27 | 2018-08-27 | null | 02 | N | NAB-PACLITAXEL | 100048321 |
| 170002280 | 170003574 | 1.66 | 98.8 | Palliative (P) | null | 2020-01-15 | null | N | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100044243 |